The outcomes of concomitant chemoradiotherapy followed by adjuvant chemotherapy with temozolomide for newly diagnosed high grade gliomas: The preliminary results of single center prospective study

Journal of Korean Neurosurgical Society

Volumn 44, Issue 4, 2008, Pages 222-227

  Choi, Jung Won ^a   Lee, Min Mi ^a   Kim, In Ah ^a   Kim, Jee Hyun ^a   Choe, Gheeyoung ^a   Kim, Chae Yong ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

Concomitant chemoradiotherapy; Glioblastoma; High grade glioma; Temozolomide

Indexed keywords

TEMOZOLOMIDE;

ADJUVANT THERAPY; ADOLESCENT; ADULT; ANEMIA; ARTICLE; BRAIN SURGERY; CANCER GRADING; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; GLIOBLASTOMA; GLIOMA; GLIOSIS; HISTOPATHOLOGY; HUMAN; KARNOFSKY PERFORMANCE STATUS; KOREA; LEUKOPENIA; MALE; MULTIPLE CYCLE TREATMENT; MUSCLE WEAKNESS; NAUSEA AND VOMITING; OLIGODENDROGLIOMA; OVERALL SURVIVAL; STEREOTAXIC SURGERY; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 57049139011     PISSN: 12258245     EISSN: 15987876     Source Type: Journal    
DOI: 10.3340/jkns.2008.44.4.222     Document Type: Article

References (18)

1. Brada M, Hoang-Xuan K, Rampling R, Dietrich PY, Dirix LY, Macdonald D, et al: Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Ann Oncol 12: 259-266, 2001
2. Brandes AA, Franceschi E, Tosoni A, Blatt V, Pession A, Tallini G, et al: MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol 26: 2192-2197, 2008
3. Cairncross G, Berkey B, Shaw E, Jenkins R, Scheithauer B, Brachman D, et al: Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol 24: 2707-2714, 2006
4. Corsa P, Parisi S, Raguso A, Troiano M, Perrone A, Cossa S, et al: Temozolomide and radiotherapy as first-line treatment of high-grade gliomas. Tumori 92: 299-305, 2006
5. Friedman HS, McLendon RE, Kerby T, Dugan M, Bigner SH, Henry AJ, et al: DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. J Clin Oncol 16: 3851-3857, 1998
6. Galanis E, Buckner J: Chemotherapy for high-grade gliomas. Br J Cancer 82: 1371-1380, 2000
7. Kocher M, Kunze S, Eich HT, Semrau R, Muller RP: Efficacy and toxicity of postoperative temozolomide radiochemotherapy in malignant glioma. Strahlenther Onkol 181: 157-163, 2005
8. Mahaley MS Jr, Mettlin C, Natarajan N, Laws ER Jr, Peace BB: National survey of patterns of care for brain-tumor patients. J Neurosurg 71: 826-836, 1989
9. Perry J, Laperriere N, Zuraw L, Chambers A, Spithoff K, Cairncross JG: Adjuvant chemotherapy for adults with malignant glioma: a systematic review. Can J Neurol Sci 34: 402-410, 2007
10. Sathornsumetee S, Rich JN, Reardon DA: Diagnosis and treatment of high-grade astrocytoma. Neurol Clin 25: 1111-1139, 2007
11. Siker ML, Chakravarti A, Mehta MP: Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma? Crit Rev Oncol Hematol 60: 99-111, 2006
12. Simon JM, Toubiana T, Lang P, Taillibert S, Mazeron JJ: [Radiotherapy for glioblastomas: from radiobiology to concomitant chemotherapy]. Cancer Radiother 9: 322-331, 2005
13. Stupp R, Dietrich PY, Ostermann Kraljevic S, Pica A, Maillard I, Maeder P, et al: Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 20: 1375-1382, 2002
14. Stupp R, Hegi ME, Gilbert MR, Chakravarti A: Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol 25: 4127-4136, 2007
15. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005
16. Walker MD, Alexander E Jr, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, et al: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49: 333-343, 1978
17. Walker MD, Green SB, Byar DP, Alexander E Jr, Batzdorf U, Brooks WH, et al: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303: 1323-1329, 1980
18. Yung WK, Albright RE, Olson J, Fredericks R, Fink K, Prados MD, et al: A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 83: 588-593, 2000